Sporadic Inclusion Body Myositis Correlates with Increased Expression and Cross-linking by Transglutaminases 1 and 2
Open Access
- 1 March 2000
- journal article
- Published by Elsevier
- Vol. 275 (12) , 8703-8710
- https://doi.org/10.1074/jbc.275.12.8703
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Fourteen Newly Recognized Proteins at the Human Neuromuscular Junctions‐and Their Nonjunctional Accumulation in Inclusion‐Body MyositisaaAnnals of the New York Academy of Sciences, 1998
- Pharmacologic inhibition of transglutaminase-induced cross-linking of Alzheimer's amyloid β-peptideLife Sciences, 1997
- Tissue Transglutaminase and Factor XIII in Cartilage and Bone RemodelingSeminars in Thrombosis and Hemostasis, 1996
- Inactive Zymogen and Highly Active Proteolytically Processed Membrane-Bound Forms of the Transglutaminase 1 Enzyme in Human Epidermal KeratinocytesBiochemical and Biophysical Research Communications, 1996
- Cross‐linking of β‐amyloid protein precursor catalysed by tissue transglutaminaseFEBS Letters, 1994
- Identification of glutamine and lysine residues in Alzheimer amyloid βA4 peptide responsible for transglutaminase‐catalysed homopolymerization and cross‐linking to α2M receptorFEBS Letters, 1994
- Cell Biology of the Amyloid beta-Protein Precursor and the Mechanism of Alzheimer's DiseaseAnnual Review of Cell and Developmental Biology, 1994
- Activity and Distribution of Tissue Transglutaminase in Association with Nerve‐Muscle SynapsesJournal of Neurochemistry, 1993
- Cross‐linking of a synthetic partial‐length (1–28) peptide of the Alzheimer β/A4 amyloid protein by transglutaminaseFEBS Letters, 1993
- Plasma membrane transglutaminase and cytosolic transglutaminase form distinct envelope-like structures in transformed human keratinocytesFEBS Letters, 1988